MedStar Low Risk TAVR

To assess the safety and feasibility of Transcatheter Aortic Valve Replacement (TAVR) with commercially available bioprostheses in patients with severe, symptomatic aortic stenosis (AS) who are low-risk (STS score ≤3%) for surgical aortic valve replacement (SAVR).

**Sutter Medical Center Sacramento currently enrolling to Bicuspid Aortic Valve arm of study only**

Location: SIMR (Sacramento/Valley Area)

Please contact simr@sutterhealth.org  about Study MedStar Low Risk TAVR

Principal Investigator

David K. Roberts, III, M.D., FACC

Co-Investigator(s)

Pei-Hsiu Huang, M.D. 

Recruitment Status

Active, Not Recruiting
Recruiting to Bicuspid Aortic Valve arm only.

Start Date

March 01, 2017